Lassonde Industries Inc Stock Price Today (NSE: LASA)
Fundamental Score
Lassonde Industries Inc Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Lassonde Industries Inc share price today is ₹6.93, down 0.72% on NSE/BSE as of 3 August 2026. Lassonde Industries Inc (LASA) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of ₹36.42 (Cr). The 52-week high for LASA share price is ₹14.08 and the 52-week low is ₹5.67. The company has a Return on Equity (ROE) of -19.58% and a debt-to-equity ratio of 0.20.
Lassonde Industries Inc Share Price Chart — NSE/BSE Historical Performance
Lassonde Industries Inc share price chart: -8.40% return over the past month. 52-week high ₹14.08, 52-week low ₹5.67.
Lassonde Industries Inc — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹6.81 | ₹7.14 | ₹6.80 | ₹6.87 | 64.88K (Cr) | |
| ₹7.09 | ₹7.15 | ₹6.91 | ₹6.98 | 17.65K (Cr) | |
| ₹6.86 | ₹7.17 | ₹6.66 | ₹7.09 | 28.89K (Cr) | |
| ₹6.83 | ₹7.13 | ₹6.80 | ₹6.86 | 9.69K (Cr) | |
| ₹6.98 | ₹7.18 | ₹6.76 | ₹6.82 | 22.89K (Cr) | |
| ₹7.02 | ₹7.25 | ₹6.75 | ₹6.94 | 1.63L (Cr) | |
| ₹7.12 | ₹7.29 | ₹7.06 | ₹7.10 | 12.58K (Cr) | |
| ₹7.02 | ₹7.63 | ₹7.02 | ₹7.30 | 22.31K (Cr) | |
| ₹7.12 | ₹7.33 | ₹7.12 | ₹7.13 | 13.51K (Cr) | |
| ₹7.30 | ₹7.55 | ₹7.00 | ₹7.11 | 32.79K (Cr) |
Lassonde Industries Inc — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹7.59 | ₹7.90 | ₹6.66 | ₹6.87 | -9.49% | |
| ₹8.35 | ₹8.35 | ₹6.76 | ₹7.56 | -9.46% | |
| ₹7.98 | ₹8.77 | ₹7.55 | ₹8.31 | +4.14% | |
| ₹5.67 | ₹9.00 | ₹5.67 | ₹8.00 | +41.09% | |
| ₹7.36 | ₹8.30 | ₹5.67 | ₹5.67 | -22.96% | |
| ₹9.30 | ₹9.45 | ₹7.66 | ₹7.98 | -14.19% | |
| ₹10.38 | ₹12.48 | ₹8.72 | ₹9.39 | -9.54% | |
| ₹9.54 | ₹10.28 | ₹8.51 | ₹9.44 | -1.05% | |
| ₹11.60 | ₹11.95 | ₹9.01 | ₹9.55 | -17.67% | |
| ₹11.50 | ₹12.20 | ₹9.81 | ₹11.60 | +0.87% | |
| ₹8.22 | ₹14.08 | ₹8.22 | ₹11.32 | +37.71% | |
| ₹10.04 | ₹10.81 | ₹8.16 | ₹8.22 | -18.13% |
AI Research Briefing
Powered by Gemini · 2026-04-10
Lassonde's profitability hinges on managing input costs and integrating acquisitions amidst macro uncertainty.
WHAT'S HAPPENING NOW (last 2-4 weeks)
Lassonde Industries announced its Q4 and fiscal 2025 results on March 26, 2026. Fourth-quarter sales increased by 4% to CAD 768 million, and adjusted EPS was CAD 7.52, up 46.6% from the same quarter last year. Full-year sales reached CAD 2.9 billion (+12.8%), with adjusted EBITDA of CAD 344 million. Lassonde is a finalist in two Mercuriades categories. Minh Quan Dam was appointed as the first Chief Information Officer, effective March 23, 2026.
CORE STORY (THE REAL GAME)
Lassonde is a North American food and beverage company aiming to reach CAD 3 billion in sales by the end of 2026 through strategic acquisitions and organic growth. The market is focused on Lassonde's ability to manage input costs and integrate acquisitions effectively to achieve profitable growth.
- Strong Q4 performance with increased EPS
- Sales growth driven by pricing and volume
- Strategic investments in capacity expansion
- Successful completion of New Jersey facility
- Further margin expansion through cost efficiencies
- Positive developments in trade policies
- Micro/SME cap - liquidity risk
- Volatile input costs impacting margins
- High compensation and professional fees
FII decreased by 0.47%
Uncertainty due to geopolitical events and potential trade disruptions.
Free Cash Flow 5Y: ₹39.46 Cr
Expect continued sales growth and margin expansion in the next 3-6 months, driven by capacity expansion and cost management. Monitor input costs and integration of Summer Garden.
Primary Thesis Risk
Failure to manage input costs and integrate acquisitions will kill the thesis.
For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Lassonde Industries Inc Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Lassonde Industries Inc Fundamental Analysis & Valuation Benchmarking
Educational evaluation of LASA across key market metrics for learning purposes.
Positive Indicators
2 factors identified
Conservative Debt Levels (D/E: 0.20)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Balanced Promoter Holding (53.65%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Risk Factors
9 factors identified
Below-Average Return on Equity (-19.58%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (-18.15%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Margin Pressure Concerns (2.03%)
Observation: Operating margins are below industry standards.
Analysis: OPM <5% may indicate pricing pressures or cost management challenges.
Profit Decline Concern (-138.67%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Revenue Contraction (-100.33%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions.
Limited Growth History (-34.03% CAGR)
Observation: Below-average 5-year sales growth trajectory.
Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities.
Weak Interest Coverage (-33.79x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability.
High Share Pledging Risk (20.66%)
Observation: Significant promoter share pledging creates potential overhang.
Analysis: High pledging levels may create selling pressure during market downturns.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Lassonde Industries Inc vs Pharmaceuticals Peers
Peer Comparison - Pharmaceuticals
Compare Lassonde Industries Inc with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Lassonde Industries IncLassonde Indust...Selected✓ LASA • 540702 | 0/100 | ₹6.93₹7 | ₹36.42₹36.42 | — — | -19.58%Poor -19.58% Poor | -18.15%Poor -18.15% Poor | 0.20Excellent 0.2 Excellent | — — | -34.03%Poor -34.03% Poor | 0.00% |
Sun Pharmaceutical Industries LtdSun Pharmaceuti... SUNPHARMA • 524715 | 66.4/100 | ₹1990.50₹1991 | ₹468821.49₹468821.49 | 37.73Average 37.7 Average | 15.95%Good 15.95% Good | 20.53%Excellent 20.53% Excellent | 0.06Excellent 0.1 Excellent | 16.75%Excellent 16.75% Excellent | 11.78%Good 11.78% Good | 0.82% |
Divis Laboratories LtdDivis Laborator... DIVISLAB • 532488 | 56.3/100 | ₹8056.00₹8056 | ₹193163.97₹193163.97 | 73.64Average 73.6 Average | 16.53%Good 16.53% Good | 21.96%Excellent 21.96% Excellent | 0.00Excellent 0.0 Excellent | 5.71%Good 5.71% Good | 8.67%Good 8.67% Good | 0.41% |
Torrent Pharmaceuticals LtdTorrent Pharmac... TORNTPHARM • 500420 | 51.4/100 | ₹5122.80₹5123 | ₹169902.02₹169902.02 | 77.52Average 77.5 Average | 27.43%Excellent 27.43% Excellent | 15.19%Good 15.19% Good | 1.79Average 1.8 Average | 12.07%Good 12.07% Good | 11.80%Good 11.80% Good | 0.76% |
Cipla LtdCipla Ltd... CIPLA • 500087 | 40.2/100 | ₹1473.20₹1473 | ₹116131.81₹116131.81 | 30.51Average 30.5 Average | 11.60%Average 11.60% Average | 15.49%Good 15.49% Good | 0.02Excellent 0.0 Excellent | 9.94%Good 9.94% Good | 8.01%Good 8.01% Good | 0.90% |
Zydus Lifesciences LtdZydus Lifescien... ZYDUSLIFE • 532321 | 74.1/100 | ₹1078.30₹1078 | ₹115375.77₹115375.77 | 21.26Average 21.3 Average | 21.25%Excellent 21.25% Excellent | 21.14%Excellent 21.14% Excellent | 0.46Excellent 0.5 Excellent | 18.77%Excellent 18.77% Excellent | 12.45%Good 12.45% Good | 0.09% |
Lupin LtdLupin Ltd... LUPIN • 500257 | 83.4/100 | ₹2415.00₹2415 | ₹113976.53₹113976.53 | 20.04Average 20.0 Average | 28.68%Excellent 28.68% Excellent | 29.93%Excellent 29.93% Excellent | 0.29Excellent 0.3 Excellent | 37.02%Excellent 37.02% Excellent | 13.02%Good 13.02% Good | 0.72% |
Mankind Pharma LtdMankind Pharma ... MANKIND • 543904 | 61.5/100 | ₹2469.60₹2470 | ₹105053.91₹105053.91 | 52.29Average 52.3 Average | 13.12%Average 13.12% Average | 13.50%Average 13.50% Average | 0.39Excellent 0.4 Excellent | 10.52%Good 10.52% Good | 18.10%Excellent 18.10% Excellent | 0.04% |
Dr Reddys Laboratories LtdDr Reddys Labor... DRREDDY • 500124 | 41/100 | ₹1148.10₹1148 | ₹102660.46₹102660.46 | 25.62Average 25.6 Average | 11.22%Average 11.22% Average | 13.04%Average 13.04% Average | 0.20Excellent 0.2 Excellent | 15.44%Excellent 15.44% Excellent | 12.09%Good 12.09% Good | 0.65% |
Aurobindo Pharma LtdAurobindo Pharm... AUROPHARMA • 524804 | 24.6/100 | ₹1580.20₹1580 | ₹90035.87₹90035.87 | 25.38Average 25.4 Average | 10.06%Average 10.06% Average | 12.80%Average 12.80% Average | 0.21Excellent 0.2 Excellent | 0.80%Average 0.80% Average | 6.32%Good 6.32% Good | 0.26% |
Laurus Labs LtdLaurus Labs Ltd... LAURUSLABS • 540222 | 34.1/100 | ₹1816.20₹1816 | ₹84016.75₹84016.75 | 93.94Average 93.9 Average | 18.30%Good 18.30% Good | 17.76%Good 17.76% Good | 0.48Excellent 0.5 Excellent | -1.89%Poor -1.89% Poor | 7.19%Good 7.19% Good | 0.13% |
Top Pharmaceuticals Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Sun Pharmaceutical Industries Ltd share price468821.49 Cr
- Divis Laboratories Ltd share price193163.97 Cr
- Torrent Pharmaceuticals Ltd share price169902.02 Cr
- Cipla Ltd share price116131.81 Cr
- Zydus Lifesciences Ltd share price115375.77 Cr
Lassonde Industries Inc Quarterly Performance
Latest quarterly metrics for LASA — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
-100.33%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
-138.67%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
-34.03%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
N/A
Compounded annual net profit growth over 5 years
Lassonde Industries Inc Technical Indicators
SMA 50, SMA 200, RSI and volume signals for LASA — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Lassonde Industries Inc Financial Statements
Annual income statement, balance sheet and cash flow for Lassonde Industries Inc (LASA) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Lassonde Industries Inc
About LASA (Lassonde Industries Inc)
Lassonde Industries Inc. is a multifaceted North American leader renowned for its diverse portfolio of high-quality food and beverage products. While not directly operating within ...the pharmaceutical sector, Lassonde's focus on wellness and nutrition resonates deeply with the principles underlying the health and pharmaceutical industries. The company meticulously sources ingredients and employs advanced processing techniques to ensure the integrity and nutritional value of its products, a commitment that mirrors the rigorous standards applied in pharmaceutical manufacturing. Lassonde's extensive research and development efforts are dedicated to creating innovative products that cater to evolving consumer needs and preferences, reflecting a similar drive for innovation found in pharmaceutical research aimed at developing new and improved treatments. Lassonde's expertise in the food and beverage industry translates into a deep understanding of consumer health trends and dietary requirements. This knowledge base allows the company to formulate products that promote overall well-being and support specific health goals. Their range of fruit juices, vegetable juices, smoothies, and plant-based beverages demonstrates a commitment to providing consumers with convenient and nutritious options. This focus on preventative health and wellness, through carefully crafted food and beverage offerings, aligns with the broader healthcare landscape, contributing to a more health-conscious society. The company's dedication to quality and safety further reinforces its commitment to consumer well-being. Lassonde Industries Inc. operates with a strong sense of corporate social responsibility, prioritizing sustainable practices and ethical sourcing. This commitment extends to its supply chain, ensuring that ingredients are obtained responsibly and with minimal environmental impact. Lassonde's dedication to transparency and traceability in its operations builds trust with consumers and stakeholders alike. While not a pharmaceutical company, Lassonde's dedication to ethical practices, consumer health, and innovative product development mirrors the core values of the healthcare industry and demonstrates a clear commitment to enhancing the overall well-being of its consumers.
Company Details
Key Leadership
Corporate Events
LASA Share Price: Frequently Asked Questions
What is the current share price of Lassonde Industries Inc?
Lassonde Industries Inc (LASA) trades at ₹6.93 on NSE and BSE. Market cap ₹36.42 (Cr). Educational data only.
What is the P/E ratio of Lassonde Industries Inc?
Lassonde Industries Inc has a P/E of N/Ax vs industry average 34.89x.
What is the Bull Run score for Lassonde Industries Inc?
Lassonde Industries Inc has a Bull Run score of 0/100 based on 25+ financial parameters.
Does Lassonde Industries Inc pay dividends?
Lassonde Industries Inc has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Lassonde Industries Inc?
Lassonde Industries Inc has ROE of -19.58%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Lassonde Industries Inc?
Lassonde Industries Inc has debt-to-equity of 0.20.
Is Lassonde Industries Inc a good investment?
Bull Run gives Lassonde Industries Inc a score of 0/100. This is not investment advice — consult a SEBI-registered advisor.